The table below shows NEOGENOMICS INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$5.23M
$7.02M
-$1.95M
-$65.99M
-$26.72M
$1.46M
Capital expenditure
$27.01M
$41.06M
$28.75M
$30.89M
$64.14M
$29.10M
Investing cash flow
-$12.34M
$12.86M
$76.71M
$517.00K
-$632.37M
-$159.44M
Dividends paid
-
-
-
-
-
-
NEO operating cash flow (10-K history)
NEOGENOMICS INC reported operating cash flow of $5.23M for fiscal year 2025. That is down 25.5% from $7.02M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $2.23M (FY 2013) to $5.23M. Figures come from the company's audited annual reports as filed with the SEC.
